| Literature DB >> 33540244 |
Fan Yang1, Yi Chang1, Cuijuan Zhang2, Yunzhao Xiong2, Xiangting Wang1, Xuelian Ma1, Zheng Wang2, Hui Li2, Tatsuo Shimosawa3, Lin Pei4, Qingyou Xu5.
Abstract
Progression of chronic kidney disease (CKD) to uremia is often accompanied by varying degrees of lung damage and this is also an important cause of death. Although there are many studies on the mechanism of lung injury, it is not clearly understood. Inflammatory macrophages may associated with fibrosis in the lungs. Here, we investigated the role of macrophage-myofibroblast transition (MMT) in lung fibrosis with unilateral ureteral obstruction (UUO) rats. We found that cells undergoing MMT accounted for an important part of the myofibroblast population, and correlated with lung fibrosis, MMT cells in lungs have a predominant M2 phenotype, and this process was attenuated after treatment with eplerenone. In conclusion, our studies provide a possible mechanism for UUO-induced kidney damage and lung injury, indicating the possibility of using eplerenone, a mineralocorticoid receptor blocker, to treat UUO to reduce kidney damage and protect lung function.Entities:
Keywords: Eplerenone; Macrophage-myofibroblast transition; Mineralocorticoid receptor; Pulmonary fibrosis; Unilateral ureteral obstruction
Mesh:
Substances:
Year: 2021 PMID: 33540244 DOI: 10.1016/j.intimp.2021.107396
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932